CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation

Recent evidence suggests that hepatic dendritic cells (HDCs) contribute to the evolution of chronic liver diseases. However, the HDC subsets involved and the mechanisms driving these responses are still poorly understood. In this study, we have investigated the role of the fractalkine receptor CX<...

Full description

Bibliographic Details
Main Authors: Salvatore Sutti, Stefania Bruzzì, Felix Heymann, Anke Liepelt, Oliver Krenkel, Alberto Toscani, Naresh Naik Ramavath, Diego Cotella, Emanuele Albano, Frank Tacke
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/9/1099
_version_ 1827842671650013184
author Salvatore Sutti
Stefania Bruzzì
Felix Heymann
Anke Liepelt
Oliver Krenkel
Alberto Toscani
Naresh Naik Ramavath
Diego Cotella
Emanuele Albano
Frank Tacke
author_facet Salvatore Sutti
Stefania Bruzzì
Felix Heymann
Anke Liepelt
Oliver Krenkel
Alberto Toscani
Naresh Naik Ramavath
Diego Cotella
Emanuele Albano
Frank Tacke
author_sort Salvatore Sutti
collection DOAJ
description Recent evidence suggests that hepatic dendritic cells (HDCs) contribute to the evolution of chronic liver diseases. However, the HDC subsets involved and the mechanisms driving these responses are still poorly understood. In this study, we have investigated the role of the fractalkine receptor CX<sub>3</sub>CR1 in modulating monocyte-derived dendritic cell (moDC) differentiation during liver inflammation. The phenotype of HDC and functional relevance of CX<sub>3</sub>CR1 was assessed in mice following necro-inflammatory liver injury induced by the hepatotoxic agent carbon tetrachloride (CCl<sub>4</sub>) and in steatohepatitis caused by a methionine/choline-deficient (MCD) diet. In both the experimental models, hepatic inflammation was associated with a massive expansion of CD11c<sup>+</sup>/MHCII<sup>high</sup>/CD11b<sup>+</sup> myeloid HDCs. These cells also expressed the monocyte markers Ly6C, chemokine (C-C Motif) receptor 2 (CCR2), F4/80 and CD88, along with CX<sub>3</sub>CR1, allowing their tentative identification as moDCs. Mice defective in CX<sub>3</sub>CR1 showed a reduction in liver-moDC recruitment following CCl<sub>4</sub> poisoning in parallel with a defective maturation of monocytes into moDCs. The lack of CX<sub>3</sub>CR1 also affected moDC differentiation from bone marrow myeloid cells induced by granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) in vitro. In wild-type mice, treatment with the CX<sub>3</sub>CR1 antagonist CX3-AT (150 &#181;g, i.p.) 24 h after CCl<sub>4</sub> administration reduced liver moDC<sub>S</sub> and significantly ameliorated hepatic injury and inflammation. Altogether, these results highlight the possible involvement of moDCs in promoting hepatic inflammation following liver injury and indicated a novel role of CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 dyad in driving the differentiation of hepatic moDCs.
first_indexed 2024-03-12T08:14:04Z
format Article
id doaj.art-97a670bf0c61454db67261d87b998d2c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T08:14:04Z
publishDate 2019-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-97a670bf0c61454db67261d87b998d2c2023-09-02T19:01:17ZengMDPI AGCells2073-44092019-09-0189109910.3390/cells8091099cells8091099CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic InflammationSalvatore Sutti0Stefania Bruzzì1Felix Heymann2Anke Liepelt3Oliver Krenkel4Alberto Toscani5Naresh Naik Ramavath6Diego Cotella7Emanuele Albano8Frank Tacke9Department of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Hepatology and Gastroenterology, Charité University Medical Center Berlin, 10117 Berlin, GermanyDepartment of Medicine III, RWTH-University Hospital Aachen, 52074 Aachen, GermanyDepartment of Medicine III, RWTH-University Hospital Aachen, 52074 Aachen, GermanyDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Via Solaroli 17, 28100 Novara, ItalyDepartment of Hepatology and Gastroenterology, Charité University Medical Center Berlin, 10117 Berlin, GermanyRecent evidence suggests that hepatic dendritic cells (HDCs) contribute to the evolution of chronic liver diseases. However, the HDC subsets involved and the mechanisms driving these responses are still poorly understood. In this study, we have investigated the role of the fractalkine receptor CX<sub>3</sub>CR1 in modulating monocyte-derived dendritic cell (moDC) differentiation during liver inflammation. The phenotype of HDC and functional relevance of CX<sub>3</sub>CR1 was assessed in mice following necro-inflammatory liver injury induced by the hepatotoxic agent carbon tetrachloride (CCl<sub>4</sub>) and in steatohepatitis caused by a methionine/choline-deficient (MCD) diet. In both the experimental models, hepatic inflammation was associated with a massive expansion of CD11c<sup>+</sup>/MHCII<sup>high</sup>/CD11b<sup>+</sup> myeloid HDCs. These cells also expressed the monocyte markers Ly6C, chemokine (C-C Motif) receptor 2 (CCR2), F4/80 and CD88, along with CX<sub>3</sub>CR1, allowing their tentative identification as moDCs. Mice defective in CX<sub>3</sub>CR1 showed a reduction in liver-moDC recruitment following CCl<sub>4</sub> poisoning in parallel with a defective maturation of monocytes into moDCs. The lack of CX<sub>3</sub>CR1 also affected moDC differentiation from bone marrow myeloid cells induced by granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) in vitro. In wild-type mice, treatment with the CX<sub>3</sub>CR1 antagonist CX3-AT (150 &#181;g, i.p.) 24 h after CCl<sub>4</sub> administration reduced liver moDC<sub>S</sub> and significantly ameliorated hepatic injury and inflammation. Altogether, these results highlight the possible involvement of moDCs in promoting hepatic inflammation following liver injury and indicated a novel role of CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 dyad in driving the differentiation of hepatic moDCs.https://www.mdpi.com/2073-4409/8/9/1099dendritic cellsliver injuryfractalkinecarbon tetrachloride
spellingShingle Salvatore Sutti
Stefania Bruzzì
Felix Heymann
Anke Liepelt
Oliver Krenkel
Alberto Toscani
Naresh Naik Ramavath
Diego Cotella
Emanuele Albano
Frank Tacke
CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
Cells
dendritic cells
liver injury
fractalkine
carbon tetrachloride
title CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
title_full CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
title_fullStr CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
title_full_unstemmed CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
title_short CX<sub>3</sub>CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation
title_sort cx sub 3 sub cr1 mediates the development of monocyte derived dendritic cells during hepatic inflammation
topic dendritic cells
liver injury
fractalkine
carbon tetrachloride
url https://www.mdpi.com/2073-4409/8/9/1099
work_keys_str_mv AT salvatoresutti cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT stefaniabruzzi cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT felixheymann cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT ankeliepelt cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT oliverkrenkel cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT albertotoscani cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT nareshnaikramavath cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT diegocotella cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT emanuelealbano cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation
AT franktacke cxsub3subcr1mediatesthedevelopmentofmonocytederiveddendriticcellsduringhepaticinflammation